Efficacy of internal and external teat sealants on cure and new infection risk in dry-off protocols for Holstein cows

J. McArt, M. Wieland
{"title":"Efficacy of internal and external teat sealants on cure and new infection risk in dry-off protocols for Holstein cows","authors":"J. McArt, M. Wieland","doi":"10.3168/jdsc.2024-0574","DOIUrl":null,"url":null,"abstract":": Internal teat sealant products have been used alone or in combination with antibiotic dry cow treatment to prevent new IMI over the dry period in dairy cows. Conversely, knowledge about the efficacy of external teat sealants in the prevention of IMI is scarce. The objective of our study was to investigate the effect of 2 different teat sealants, one internal teat sealant and one external teat sealant, on the (1) risk of new IMI during the dry period, (2) risk of IMI cure, (3) first test day linear somatic cell score, (4) first test day milk yield, (5) incidence of farm-diagnosed clinical mastitis ≤ 30 DIM, and (6) incidence of culling ≤ 30 DIM. In a randomized clinical trial, Holstein cows (n = 1,500) from one commercial dairy were assigned to treatment and control groups. At dry off, cows in the treatment groups received an antibiotic dry cow treatment in combination with either an internal teat sealant (INT) or a single application of an external teat sealant (EXT). Control (CON) cows received the antibiotic dry cow treatment alone. Data on linear somatic cell score from the last DHI test day before dry off and the first test after calving, first test day milk yield, and the occurrence of farm-diagnosed clinical mastitis and culling ≤ 30 DIM were obtained from the farm management program. New IMI and cure of IMI during the dry period were calculated. Linear somatic cell score (mean ± SD) at first test day after calving differed among groups and was 3.2 ± 2.2 in CON, 2.8 ± 2.0 in INT, and 3.0 ± 2.1 in EXT groups. The risk of new IMI differed among groups and was 30.2% for CON cows, 18.2% for INT cows, and 22.6% for EXT cows. A Poisson regression analysis revealed that, compared with CON cows, the risks of new IMI were 40% lower for INT cows (risk ratio (RR) = 0.60, 95% CI = 0.41 to 0.88) and 25% lower for EXT cows (RR = 0.75, 95% CI = 0.52 to 1.07). By contrast, no meaningful differences were documented for cure risk, clinical mastitis risk during the first 30 DIM, or culling risk within the first 30 DIM. In summary, cows dried off with an INT in combination with antibiotic dry cow treatment had a lower linear somatic cell score at first test day after calving and reduced risk of new IMI than cows dried off with an EXT in addition to antibiotic dry cow treatment or cows dried off using antibiotic dry cow treatment alone. Further, we found supporting evidence that cows dried off with an EXT in addition to antibiotic dry cow treatment might have an advantage in reduced new IMI over cows dried off with an antibiotic dry cow treatment alone.","PeriodicalId":94061,"journal":{"name":"JDS communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JDS communications","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.3168/jdsc.2024-0574","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

: Internal teat sealant products have been used alone or in combination with antibiotic dry cow treatment to prevent new IMI over the dry period in dairy cows. Conversely, knowledge about the efficacy of external teat sealants in the prevention of IMI is scarce. The objective of our study was to investigate the effect of 2 different teat sealants, one internal teat sealant and one external teat sealant, on the (1) risk of new IMI during the dry period, (2) risk of IMI cure, (3) first test day linear somatic cell score, (4) first test day milk yield, (5) incidence of farm-diagnosed clinical mastitis ≤ 30 DIM, and (6) incidence of culling ≤ 30 DIM. In a randomized clinical trial, Holstein cows (n = 1,500) from one commercial dairy were assigned to treatment and control groups. At dry off, cows in the treatment groups received an antibiotic dry cow treatment in combination with either an internal teat sealant (INT) or a single application of an external teat sealant (EXT). Control (CON) cows received the antibiotic dry cow treatment alone. Data on linear somatic cell score from the last DHI test day before dry off and the first test after calving, first test day milk yield, and the occurrence of farm-diagnosed clinical mastitis and culling ≤ 30 DIM were obtained from the farm management program. New IMI and cure of IMI during the dry period were calculated. Linear somatic cell score (mean ± SD) at first test day after calving differed among groups and was 3.2 ± 2.2 in CON, 2.8 ± 2.0 in INT, and 3.0 ± 2.1 in EXT groups. The risk of new IMI differed among groups and was 30.2% for CON cows, 18.2% for INT cows, and 22.6% for EXT cows. A Poisson regression analysis revealed that, compared with CON cows, the risks of new IMI were 40% lower for INT cows (risk ratio (RR) = 0.60, 95% CI = 0.41 to 0.88) and 25% lower for EXT cows (RR = 0.75, 95% CI = 0.52 to 1.07). By contrast, no meaningful differences were documented for cure risk, clinical mastitis risk during the first 30 DIM, or culling risk within the first 30 DIM. In summary, cows dried off with an INT in combination with antibiotic dry cow treatment had a lower linear somatic cell score at first test day after calving and reduced risk of new IMI than cows dried off with an EXT in addition to antibiotic dry cow treatment or cows dried off using antibiotic dry cow treatment alone. Further, we found supporting evidence that cows dried off with an EXT in addition to antibiotic dry cow treatment might have an advantage in reduced new IMI over cows dried off with an antibiotic dry cow treatment alone.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在荷斯坦奶牛干离乳方案中,内部和外部乳头密封剂对治愈和新感染风险的功效
:乳头内侧密封剂产品可单独使用,也可与抗生素干奶牛治疗结合使用,以防止奶牛在干奶期发生新的IMI。相反,有关外部乳头密封剂在预防IMI方面功效的知识却很少。我们的研究目的是调查两种不同的乳头密封剂(一种是内部乳头密封剂,另一种是外部乳头密封剂)对以下方面的影响:(1)干奶期新发IMI的风险;(2)IMI治愈的风险;(3)首个测试日的线性体细胞评分;(4)首个测试日的产奶量;(5)干奶期≤30天时牧场诊断为临床乳腺炎的发生率;以及(6)干奶期≤30天时淘汰的发生率。在一项随机临床试验中,来自一家商业奶牛场的荷斯坦奶牛(n = 1,500 头)被分配到治疗组和对照组。干奶时,治疗组奶牛接受抗生素干奶治疗,同时使用乳头内部密封剂(INT)或单次使用乳头外部密封剂(EXT)。对照组(CON)奶牛只接受抗生素干牛处理。干奶前最后一次DHI测试日和产犊后第一次测试的线性体细胞评分、第一次测试日的产奶量、牧场诊断的临床乳腺炎发生率和≤30 DIM的淘汰率等数据均来自牧场管理程序。计算干燥期新发生的IMI和IMI治愈率。产犊后第一个测试日的线性体细胞评分(平均值 ± SD)在各组之间存在差异,CON 组为 3.2 ± 2.2,INT 组为 2.8 ± 2.0,EXT 组为 3.0 ± 2.1。不同组别的奶牛发生新IMI的风险不同,CON组为30.2%,INT组为18.2%,EXT组为22.6%。泊松回归分析显示,与CON奶牛相比,INT奶牛新发IMI的风险低40%(风险比(RR)= 0.60,95% CI = 0.41至0.88),EXT奶牛低25%(RR = 0.75,95% CI = 0.52至1.07)。相比之下,在治愈风险、前 30 DIM 期间的临床乳腺炎风险或前 30 DIM 期间的淘汰风险方面,没有发现有意义的差异。总之,与除使用抗生素干牛处理外还使用EXT干牛或仅使用抗生素干牛处理的奶牛相比,使用INT干牛并结合抗生素干牛处理的奶牛在产犊后第一个测试日的线性体细胞评分较低,新发IMI的风险也较低。此外,我们还发现,有支持性证据表明,与仅使用抗生素干牛疗法干化的奶牛相比,除使用抗生素干牛疗法外还使用EXT干化的奶牛在减少新发IMI方面可能更有优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
JDS communications
JDS communications Animal Science and Zoology
CiteScore
2.00
自引率
0.00%
发文量
0
期刊最新文献
Table of Contents Editorial Board Hot topic: Influenza A H5N1 virus exhibits a broad host range, including dairy cows Hot topic: Epidemiological and clinical aspects of highly pathogenic avian influenza H5N1 in dairy cattle Hot topic: Avian influenza subtype H5N1 in US dairy—A preliminary dairy foods perspective
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1